 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Midatech Pharma plc
MTP
|
245 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
17.9 |
- |
-19.68 % |
$ 18.4 M |
Canada |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
4.89 |
$ 0.9 |
-2.33 % |
$ 6.62 M |
China |
 |
ACADIA Pharmaceuticals
ACAD
|
332 |
$ 21.96 |
-0.68 % |
$ 3.64 B |
USA |
 |
RedHill Biopharma Ltd.
RDHL
|
55.4 |
$ 1.02 |
-0.49 % |
$ 428 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
237 |
$ 21.41 |
1.9 % |
$ 1 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
104 |
- |
- |
- |
Russia |
 |
BioDelivery Sciences International
BDSI
|
436 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeterna Zentaris
AEZS
|
115 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
223 |
$ 4.08 |
0.25 % |
$ 436 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
291 |
$ 23.26 |
1.75 % |
$ 2.96 B |
USA |
 |
Cara Therapeutics
CARA
|
52.4 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
129 |
$ 1.44 |
-5.88 % |
$ 383 M |
Britain |
 |
BioXcel Therapeutics
BTAI
|
1.66 K |
$ 1.06 |
-3.64 % |
$ 12.9 M |
USA |
 |
CASI Pharmaceuticals
CASI
|
135 |
- |
- |
$ 35.4 M |
USA |
 |
bluebird bio
BLUE
|
127 |
- |
- |
$ 546 M |
USA |